XRF Scientific Pays US$4M for Bruker’s Gas Analysis Unit and New Industrial Markets
XRF Scientific expands analytical instrument portfolio with USD $4m Bruker acquisition
XRF Scientific (ASX: XRF) has acquired Bruker’s Combustion Gas Analysis business via a binding Asset Purchase Agreement, with completion imminent this week. The USD $4m upfront cash acquisition, funded from existing reserves, adds four analytical instruments to XRF’s portfolio for elemental analysis of carbon, sulfur, oxygen, hydrogen and nitrogen.
The CGA product range employs three technologies — Hot Extraction, Inert Gas Fusion, and Combustion by induction heating — to deliver rapid and precise elemental analysis across industrial applications. Under the agreement, product names such as “G4 Icarus” will be transferred and rebranded as XRF Scientific. The purchase price includes approximately USD $0.8m of inventory and demonstration instruments valued at cost.
An earnout of up to USD $1m applies, calculated at 7% of net CGA revenue over three years post-completion and paid semi-annually in arrears. There were no conditions precedent to completion.
The acquisition represents a low-risk bolt-on transaction, immediately expanding XRF’s analytical instrument range with profitable, established products from a respected global technology company. The CGA business generated unaudited revenue of USD $5.3m in 2025, including instruments, spare parts and servicing.
When big ASX news breaks, our subscribers know first
What is combustion gas analysis?
Combustion gas analysis involves measuring the precise elemental content of materials — specifically carbon, sulfur, oxygen, hydrogen and nitrogen. These elements significantly influence material properties such as strength, durability, corrosion resistance and performance under stress. Industrial manufacturers require exact compositional data to meet quality specifications, maintain process control, and ensure product consistency.
The CGA instruments acquired from Bruker employ three distinct analytical technologies:
Hot Extraction: Heats samples to elevated temperatures in a controlled atmosphere, causing target elements to be released as gases which are then measured.
Inert Gas Fusion: Melts samples in an inert gas environment (typically argon or helium), allowing oxygen, nitrogen and hydrogen to be extracted and quantified without interference from atmospheric contamination.
Combustion by induction heating: Uses electromagnetic induction to rapidly heat and combust samples, releasing carbon and sulfur as measurable gases.
These technologies serve mission-critical quality control functions across heavy industry. Manufacturers must verify elemental composition at multiple production stages — from raw material receipt through to final product testing. Recurring demand for CS/OHN analysis is driven by production requirements and regulatory compliance, not discretionary spending. A steel producer, for example, cannot reduce carbon testing when market conditions weaken; every batch requires verification to meet specifications.
Blue-chip customer base spanning global industrial sectors
The CGA business serves a predominantly industrial customer base spanning Europe, North America and Asia. Sales are conducted primarily through third-party distributors, which XRF expects to maintain and expand upon. Key sectors served include:
- Nuclear energy materials
- Magnetic materials including rare earths
- Powder metallurgy and additive manufacturing
- Welding industries
- Ores and minerals (mining and exploration)
- Iron, steel, cobalt and nickel production
- Metal processing (copper, aluminium, magnesium, stainless steel, high strength steels)
- Cement manufacturing
- Glass and ceramics manufacturing
- Limestone, lime and dolomite materials
The acquisition provides XRF with diversified industry exposure beyond its traditional mining focus, reducing sector concentration risk. Where XRF’s existing product suite has strong penetration in mining and exploration laboratories, the CGA range derives the majority of revenue from industrial manufacturing sectors. This geographic and sectoral diversification strengthens the company’s resilience to commodity cycle volatility.
Historical revenue performance
The CGA business produced USD $5.3m in unaudited revenue for 2025, including instruments, spare parts and servicing. This revenue figure is based on management accounts provided by Bruker.
Unaudited Financial Data
The historical financial information relating to the CGA business is based on unaudited management accounts provided by Bruker and has not been independently verified or audited by XRF or its advisers. Investors should exercise caution in placing reliance on such figures. Past performance is not a reliable indicator of future performance.
Production transfer and revenue timeline
The CGA products are currently manufactured in Karlsruhe, Germany, with production to be transferred to XRF’s factory in Perth, Australia. The parties are immediately executing an agreed transition plan to ensure continuity of product quality and customer support. The transfer is expected to conclude during Q3 2026 (calendar year).
Key sales management and technical support employees based in Germany and the United States will join XRF to maintain customer relationships and technical expertise during the transition. Bruker will support the transfer process to ensure the CGA range continues to deliver the high-quality performance it is known for globally.
Under the Asset Purchase Agreement, XRF is entitled to all customer purchase orders received from the date of completion onwards. Bruker will complete orders received prior to completion. Revenue is therefore expected to commence after production has been transferred to Perth, starting Q4 2026 (calendar year).
| Milestone | Expected Timing |
|---|---|
| APA Completion | Imminent (April 2026) |
| Production transfer complete | Q3 2026 |
| Revenue commencement | Q4 2026 |
This timeline allows XRF to establish manufacturing capability, quality assurance protocols and supply chain arrangements in Perth before assuming full revenue responsibility. The transition period minimises execution risk while preserving customer relationships built over decades by Bruker.
Strategic rationale and cross-selling opportunities
The CGA acquisition is highly complementary to XRF’s existing analytical instrument range, creating multiple revenue growth vectors and operational synergies. The transaction delivers several strategic benefits:
- Low-risk bolt-on acquisition with complementary products — the CGA range integrates seamlessly into XRF’s existing manufacturing and distribution infrastructure
- Profitable product line expected to generate positive returns — the business has demonstrated consistent revenue generation and profitability
- Expansion into non-mining industrial sectors — reduces concentration risk and expands addressable market
- New consumable revenue streams — CGA instruments require consumables for operation, creating recurring revenue
- Cross-selling opportunities with existing products — xrTGA, Labfit CS-123 and xrFuse serve overlapping customer bases
The consumable revenue opportunity is particularly significant. CS/OHN analysers require crucibles, flux reagents and calibration standards to operate. These consumables are used every time a sample is analysed, generating predictable recurring revenue tied to customer production volumes. XRF already manufactures and supplies consumables for its fusion and sample preparation equipment, providing established channels to distribute CGA consumables globally.
Cross-selling potential exists across XRF’s analytical instrument portfolio. A mining laboratory purchasing XRF’s xrFuse sample preparation equipment may also require CS/OHN analysis capability. Similarly, steel manufacturers using CGA instruments may benefit from XRF’s thermal analysis products. The combined product range positions XRF to serve broader analytical requirements within existing customer facilities.
Management commentary
Vance Stazzonelli, Managing Director, XRF Scientific
“We are incredibly excited to complete this acquisition of Bruker’s CGA product line, expanding our range of analytical instruments. Bruker is a company we strongly admire and have collaborated with for over a decade, in joint promotion of our x-ray fluorescence related products. Their products are world-class and known for quality, reliability and generating excellent analytical results. Whilst the CGA product range is non-core to Bruker, it will form a material part of our business and future growth plans. We look forward to supporting existing CGA customers and their laboratory operations around the world.”
Frank Burgaezy, President, Bruker AXS Division
“We are glad to transfer our CGA product line to XRF Scientific. While the CGA business was not in line with the core business of the Bruker AXS Division, it will be in good hands with our long-standing partner XRF Scientific. We are convinced that XRF Scientific continues the professional support of our worldwide CGA customer base and will drive the CGA business to further growth.”
The management commentary highlights the decade-long partnership between XRF and Bruker, providing confidence in the transition process. Bruker’s endorsement of XRF’s capability to support the global CGA customer base reduces integration risk.
Acquisition funding and financial structure
The transaction is structured to align purchase price with actual revenue performance whilst preserving XRF’s balance sheet flexibility:
- USD $4m upfront cash consideration (funded from existing cash reserves)
- Approximately USD $0.8m of inventory and demonstration instruments valued at cost included in purchase price
- Earnout of up to USD $1m payable over three years
- Earnout rate: 7% of net CGA revenue (products and services)
- Earnout period: three years post-completion
- Payment frequency: semi-annually in arrears
The cash-funded structure avoids equity dilution or debt. XRF maintains financial flexibility to pursue additional growth opportunities whilst integrating the CGA business. The earnout mechanism reduces acquisition risk by tying a portion of the purchase price to actual post-acquisition revenue performance. If the business underperforms expectations, total consideration paid reduces proportionally.
The 7% revenue-based earnout provides Bruker with ongoing participation in CGA business performance, aligning incentives during the transition period. Semi-annual payments in arrears allow XRF to fund earnout obligations from CGA cash flows rather than drawing on corporate reserves.
The next major ASX story will hit our subscribers first
What this means for XRF shareholders
XRF shareholders gain immediate exposure to a profitable, established product line from a respected global peer. The acquisition expands the company’s analytical instrument portfolio, extends geographic reach into European and North American industrial markets, and diversifies revenue away from mining sector concentration.
The CGA business brings recurring revenue streams from consumables and servicing, which are less cyclical than capital equipment sales. Once production transfers to Perth in Q4 2026, XRF can cross-sell CGA instruments into its existing customer base whilst offering its fusion and thermal analysis products to CGA customers. This bidirectional cross-selling potential creates multiple pathways to revenue growth.
The transaction is funded entirely from existing cash reserves without debt or equity dilution. The earnout structure aligns total consideration with actual performance, reducing integration risk. No revenue contribution is expected until Q4 2026, allowing management time to complete the production transfer and establish quality assurance protocols before assuming full commercial responsibility.
For a company with established manufacturing capability and global distribution infrastructure, the CGA acquisition represents a logical portfolio expansion. XRF gains diversified industrial exposure, recurring consumable revenue, and cross-selling synergies whilst maintaining balance sheet strength.
Want the Next Industrial Breakout in Your Inbox?
Join 20,000+ investors receiving FREE ASX alerts on industrial manufacturing and materials technology stocks—delivered within minutes of release with in-depth analysis included. Click the “Free Alerts” button at StockWire X to get breaking news the moment it hits the market.